Life Insurance
Consensus Index

AI Consensus Fit Review

Transamerica Simplified-Issue Final Expense Insurance Fit Review

Transamerica is a good fit for Simplified-Issue Final Expense Insurance, according to five of the six AI platforms that returned a usable fit assessment.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Transamerica is a good fit for Simplified-Issue Final Expense Insurance, according to five of the six AI platforms that returned a usable fit assessment. It was named during the ranking stage by five of seven included platforms (71.4% of platform responses), with an average listed rank of 3.8 and a best rank of 1. The strongest reason to consider it is underwriting flexibility: Transamerica's simplified-issue whole life products use health questions with no traditional medical exam and are described as accepting some paired health conditions that stricter carriers decline [1]. The main limitation is price: multiple platforms report Transamerica premiums running 20–50% above leading competitors for healthier applicants, and public sources conflict on maximum coverage, product naming, and current pricing [3].

Research Snapshot

FieldFinding
Platform mentions in ranking stage5 of 7 included platforms (deepseek, google, grok, kimi, openai)
Share of included platform responses71.4%
Average listed rank3.8
Best listed rank1 (openai)
Relevant product/model/planFE Express Solution / Express Select, plus Immediate Solution, 10-Pay Solution, and Easy Solution variants
Overall use-case fitGood (5 platforms), Mixed (1 platform: grok)
Research date2026-09-21

Why Transamerica Qualified for This Study

Questions This Section Answers

  • Why did AI platforms recommend Transamerica for simplified-issue final expense insurance with no medical exam?
  • Is Transamerica a good choice for a buyer who wants permanent final expense coverage using health questions only?

Transamerica qualified because its final expense whole life line is built around simplified-issue underwriting — health questions with no traditional medical exam — which is the exact structure this study's buyer profile requires [5]. The category criterion for this study is a buyer willing to provide health information in exchange for the possibility of lower premiums or stronger benefits than guaranteed-issue coverage, and Transamerica's Final Expense Solutions Portfolio is marketed directly to that profile [5].

Five of the seven included platforms named Transamerica during ranking discovery, and six platforms returned a usable fit assessment. Five of those six rated the fit "good"; grok rated it "mixed," citing price and complaint history [9]. Transamerica's best rank was 1 (openai), and its average listed rank was 3.8.

The company also carries financial-strength ratings that platforms cited as relevant to a permanent, long-duration promise: A (Excellent) from AM Best per one independent review, and an A+ (Superior) category reference from the AM Best ratings directory [10]. These ratings describe the insurer's claims-paying capacity, not the suitability or value of any specific policy.

The Product, Model, Plan, or Service Most Relevant to Simplified-Issue Final Expense Insurance

Questions This Section Answers

  • Which Transamerica product should a buyer choose for simplified-issue final expense coverage — FE Express Solution, Express Select, Immediate Solution, 10-Pay Solution, or Easy Solution?
  • How much coverage can a buyer get from Transamerica final expense, and does the maximum change with age?

The most relevant Transamerica offering is the Final Expense Solutions Portfolio, marketed in platform responses under names including FE Express Solution and Express Select, with additional variants called Immediate Solution, 10-Pay Solution, and Easy Solution [12]. All are described as permanent whole life coverage with level premiums, not term insurance [15].

Product naming is inconsistent across sources, and this is a material conflict rather than a settled fact. One platform explicitly flagged that it could not determine whether "Express Select" and "FE Express Solution" are the same product or distinct offerings [14]. Buyers should confirm the exact product name and policy form being quoted.

Coverage maximums are also disputed. The official consumer-facing portfolio page describes $1,000–$50,000 for ages 0–85, with a $25,000 maximum for Easy Solution at ages 18–80 [17]. A newer FE Express Solution agent guide reports up to $100,000, but that material is marked for agent use only [18]. Independent reviews split the same way: one reports FE Express Solution up to $50,000 for ages 18–75 and $25,000 for ages 76–85, with Express Select up to $100,000 under age 76 [13]; another reports up to $100,000 for FE Express [20]. The governing state-specific illustration and policy form should control.

Underwriting structure is more consistent across sources. Transamerica reviews health questions and prescription history rather than requiring a physical exam, blood work, or fluids [21]. One platform reports approximately eight health questions, more than some competitors [23]. Qualifying applicants may receive full first-day benefits, while others may be offered a graded plan [24].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Transamerica for simplified-issue final expense insurance?
  • Is Transamerica's final expense coverage permanent, and are the premiums guaranteed to stay level?

Platforms agreed on several core points, though the fit findings are not unanimous because one of six assessing platforms rated the fit "mixed."

First, the underwriting structure matches the use case. Multiple platforms independently described Transamerica final expense as simplified-issue whole life using health questions with no medical exam [26].

Second, the coverage is permanent. Platforms consistently described these as whole life policies with guaranteed level premiums that do not increase with age, plus a cash value component [31].

Third, qualifying applicants can receive full first-day benefits. One platform reported that Preferred and Standard plans carry no waiting period, while graded plans impose a two-year waiting period [34].

Fourth, underwriting is comparatively lenient for complex health profiles. One platform reported that Transamerica accepts paired conditions such as diabetes combined with COPD, insulin-dependent diabetes, or heart disease with stents for level coverage, and that it accepts some conditions Mutual of Omaha declines [36].

Fifth, the application can be fast. Company materials describe electronic applications with possible same-day approval and policy delivery in as little as 10 minutes, though one platform noted that borderline cases may be referred to manual underwriting and take longer [38].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Is Transamerica's final expense coverage limit $50,000 or $100,000, and which figure should a buyer rely on?
  • Is Transamerica available in New York for simplified-issue final expense insurance?

The largest disagreement concerns maximum coverage. Official portfolio materials describe up to $50,000 with age-based limits, while a newer agent guide and some independent reviews report up to $100,000 [40]. One platform stated plainly that this discrepancy is unresolved [42]. Buyers should treat any figure as state- and age-specific until confirmed on a quote.

Pricing evidence is directionally consistent but numerically inconsistent. Platforms reported Transamerica premiums running 20–30% above Mutual of Omaha [43], 30–50% above competitors for healthy applicants, and up to 36% above the cheapest compared carrier at age 80 [44]. Sample rates also conflict: one source lists $61 per month for a 65-year-old female nonsmoker at $10,000 of coverage [45], while another lists roughly $52 per month for a 65-year-old female at the same face amount. These are modeled or sample figures, not quotes.

New York availability is uncertain. One platform stated Transamerica sells life insurance in 49 states and is not available in New York [47], and another noted the official page says electronic application is unavailable in New York [40]. However, one platform reported that the specific FE Express state list could not be found, so New York treatment for this exact product is not fully settled.

Graded-plan terminology is inconsistent. Sources use "Easy Solution," "graded plan," and "Graded FE Express Solution" in ways that may or may not refer to the same product. One platform reported that any antipsychotic medication, regardless of indication or dosage, triggers automatic placement in a graded plan with higher premiums and a waiting period — including off-label prescriptions for insomnia, anxiety, or depression [48].

Finally, one platform reported a high NAIC complaint index, roughly four times the industry average and mostly service-related [43]. This is a single platform's characterization and was not corroborated by other platforms in this study.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Transamerica's simplified-issue final expense policy include, such as cash value, riders, or a funeral concierge service?
  • Does Transamerica final expense pay full benefits from day one, or is there a waiting period?

The features most relevant to this use case are underwriting access, benefit timing, and ancillary services.

On underwriting access, Transamerica reviews health answers and prescription history rather than ordering an exam [50]. One platform reported that the carrier accepts applicants to age 85, exceeding some competitors' age caps [52].

On benefit timing, Preferred and Standard classes are described as paying the full death benefit from day one, while graded plans limit benefits for non-accidental death during the first two years [53]. One platform reported that graded-plan benefits during the waiting period are limited to 110% of premiums paid [55].

On cash value, one independent review noted that, like many whole life policies, FE Express Solutions builds cash value over time [56]. Specific crediting rates and loan terms were not verified in the supplied sources.

On riders, published agent materials identify an accelerated death benefit rider with nursing-home benefit, an accidental-death benefit rider, and a children/grandchildren benefit rider [57]. One platform reported an optional Funeral Concierge Rider included at no additional premium cost, providing 24/7 funeral planning, legal document, and estate planning support [58]. Rider availability varies by state, and one platform noted the concierge rider is not available in all states.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Transamerica final expense insurance cost per month, and are there any policy fees?
  • Is Transamerica final expense more expensive than Mutual of Omaha for the same coverage amount?

No individualized Transamerica premium was verifiable from official consumer-facing materials, and pricing confidence was rated low by two platforms and moderate by two others. Every figure below is a sample, model, or third-party estimate — not a quote.

Source typeSample figureContext
Independent review$61/month65-year-old female nonsmoker, $10,000 coverage, Express Select
Independent review~$52/month female, ~$64/month male$10,000 non-tobacco level, age 65
Independent comparison$33/month at 50; $41 at 60; $134 at 80$10,000 coverage, female
Independent comparison$24 at 50; $33 at 60; $98 at 80Mutual of Omaha comparison at same ages

On fees, one broker-distributed product guide referenced a $15 annual policy fee for a related Transamerica final expense form, but that guide is not confirmed to reflect the current consumer product in every state [59]. One platform stated no separate consumer application fee was identified in the sources it checked. Another platform reported no reliable public fee list was verifiable.

On contract terms, premiums are described as level and guaranteed not to increase [60]. The 10-Pay Solution variant implies a limited-payment structure, but the exact payment period was not independently verified [62]. Free-look periods, lapse, reinstatement, surrender, nonforfeiture, and loan provisions require review in the issued policy and state forms.

Best Suited For

Questions This Section Answers

  • Who is Transamerica best suited for in simplified-issue final expense insurance?
  • Is Transamerica a good fit for an applicant with paired health conditions like diabetes and COPD?

Transamerica is best suited for applicants who prioritize underwriting acceptance over the lowest possible premium.

That includes applicants with paired or complex health conditions. One platform reported that Transamerica accepts diabetes combined with COPD, insulin-dependent diabetes, or heart disease with stents for level coverage, and that its underwriting is more lenient on combinations than Mutual of Omaha's [63]. Another reported favorable treatment of COPD, kidney disease, and Parkinson's without a waiting period [65].

It also includes applicants aged 76–85. One platform reported Transamerica's maximum issue age is 85, exceeding Aflac's 80-year cap and matching Mutual of Omaha's upper limit [66]. Another reported acceptance to age 85.

It includes buyers who want permanent coverage with level premiums and no exam, and who value a potentially fast electronic application. It also includes buyers who want coverage amounts above typical final expense caps, if the higher limits are confirmed for their age and state.

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Transamerica for simplified-issue final expense insurance?
  • Is Transamerica a poor choice for a healthy applicant who wants the lowest possible premium?

Transamerica is probably not the best fit for price-sensitive buyers in good health. One platform reported its premiums are the highest of three compared carriers at every age bracket, with the gap reaching 36% over the cheapest option at age 80 [67]. Another reported premiums 20–30% above Mutual of Omaha [68].

It is also a weak fit for applicants who cannot answer health questions at all. Transamerica's simplified-issue products require health disclosure; one platform noted the carrier has no guaranteed-issue fallback within the same brand, so declined applicants must seek other carriers.

Applicants taking antipsychotic medications face a specific limitation: one platform reported automatic placement in a graded plan with higher premiums and a waiting period regardless of the prescription's indication or dosage [69].

New York residents may be excluded. One platform stated Transamerica is not licensed in New York [71], though another could not confirm the FE Express state list. Buyers in New York should verify before applying.

Buyers who need very large death benefits beyond final expense limits, or who want a fully digital purchase with no agent involvement, are also poor fits — one platform noted Transamerica still requires licensed agent involvement despite its digital platform.

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Transamerica for a buyer who wants the lowest premium on simplified-issue final expense insurance?
  • When should a buyer choose guaranteed-issue coverage instead of Transamerica's simplified-issue final expense policy?

Another option may be better in four recurring situations identified across platforms.

When price is the priority and the applicant is healthy, Mutual of Omaha was named by multiple platforms as cheaper for comparable simplified-issue coverage, with one reporting it uses six health questions versus Transamerica's eight [72].

When the applicant cannot pass health questions at all, guaranteed-issue coverage from another carrier is the appropriate path, since Transamerica's simplified-issue products require health disclosure.

When the applicant is in excellent health and can pass full medical underwriting, one platform reported fully underwritten policies from competitors often offer 20–50% lower premiums.

When the buyer needs materially more coverage than final expense limits allow, a conventional whole life or larger permanent policy may be more appropriate. One platform also named Aetna/Accendo as competitive for applicants older than Transamerica's age ceiling.

Questions to Verify Before Buying

The platforms supplied overlapping verification lists. Consolidated and deduplicated, a buyer should confirm:

  1. Which exact product is being quoted — FE Express Solution, Express Select, Immediate Solution, 10-Pay Solution, or Easy Solution — and whether these differ in pricing or features.
  2. Whether the policy is immediate-benefit or graded, and the exact benefit schedule in years one and two if graded.
  3. The exact monthly premium by payment mode for the applicant's age, sex, tobacco status, health class, face amount, and state — and whether it is guaranteed not to increase.
  4. The maximum face amount for the applicant's age and state, given the $50,000 versus $100,000 conflict.
  5. Which health questions, prescription checks, and knock-out conditions apply, and whether any medication triggers automatic graded placement.
  6. Whether any policy fee, modal charge, or rider cost applies beyond the base premium.
  7. Which legal entity issues the policy — Transamerica Life Insurance Company or Transamerica Financial Life Insurance Company.
  8. Whether electronic application and instant decisioning are available in the applicant's state.
  9. The free-look, lapse, reinstatement, surrender, nonforfeiture, loan, and beneficiary provisions.
  10. Whether the agent's illustration matches the currently approved policy form and state.

Final AI Consensus Verdict

Transamerica is a good fit for simplified-issue final expense insurance, with one dissenting "mixed" rating. Five of six assessing platforms rated the fit good; grok rated it mixed on price and complaint history [73]. The consensus case rests on a direct structural match — permanent whole life, health questions, no exam — plus underwriting flexibility for complex health profiles and a high maximum issue age.

The consensus caveats are equally consistent: premiums run above leading competitors for healthier applicants, public sources conflict on maximum coverage and product naming, and no individualized premium is publicly verifiable. Platform agreement reflects how these systems characterized the product from available sources; it does not establish product quality or that Transamerica will be the best or cheapest option for any specific applicant.

The practical verdict: shortlist Transamerica, particularly if the applicant has paired health conditions or is aged 76–85, but do not select it without a state-specific quote, an underwriting result, the benefit schedule, and a comparison against at least one competing simplified-issue carrier.

How This Review Was Produced

This review synthesizes responses from seven AI platforms asked which life insurance carriers they would recommend for a consumer seeking permanent final expense insurance through simplified underwriting with health questions but no traditional medical examination. Five platforms named Transamerica during ranking discovery; six returned a usable fit assessment. The study research date is 2026-09-21. Platform-reported research dates ranged from 2026-02-14 (deepseek) to 2026-09-22 (anthropic, grok, kimi, openai, perplexity). This article evaluates Transamerica only for the simplified-issue final expense use case; it is not a broad company review. For the full carrier comparison, see the Simplified-Issue Final Expense Insurance consensus index. Buyers exploring adjacent coverage categories can also review the broader life insurance directory.

Methodology Limitations

Six of seven included platforms returned a usable fit assessment, so the fit findings should not be described as unanimous. Platform mentions in the ranking stage count only platforms that named the entity during ranking discovery, which is a different measure from fit assessment.

Platform-reported research dates differ from the authoritative run date of 2026-09-21; those dates are provenance metadata and do not independently prove freshness. Deepseek returned a research date of 2026-02-14 and ran with search disabled, so its claims are platform-reported rather than retrieved.

Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated during writing. Official-page excerpts were retrieved but not verified.

Material conflicts were preserved rather than resolved: maximum coverage ($50,000 versus $100,000), product naming (Express Select versus FE Express Solution versus graded variants), sample premium figures, and New York availability. Buyers should treat all pricing as illustrative until personally quoted.

Sources

Company-Owned Sources

  • Product Rates/Underwriting Guide for Transamerica Final Expense Solutions: https://ani.transamerica.com/ani/Uploads/Pages/52021/124013R10_0922_Final%20Expense%20Agent%20Guide_D.pdf
  • Transamerica Final Expense Solutions Portfolio: https://cloud.email.transamerica.com/final-expense/
  • Transamerica Final Expense Whole Life Product Information: https://www.transamerica.com/insurance/final-expense-insurance
  • Transamerica Simplifies Final Expense Insurance for Consumers and Agents: https://www.transamerica.com/press-release/transamerica-simplifies-final-expense-insurance-consumers-and-agents
  • Additional AI research evidence73 records
    1. AI research evidence record anthropic:44-2
    2. AI research evidence record kimi:asurgo-aflac-2026
    3. AI research evidence record grok:web:1
    4. AI research evidence record openai:c4
    5. AI research evidence record openai:c1
    6. AI research evidence record anthropic:1-1
    7. AI research evidence record deepseek:c1
    8. AI research evidence record grok:web:0
    9. AI research evidence record grok:web:1
    10. AI research evidence record anthropic:34-8
    11. AI research evidence record deepseek:c4
    12. AI research evidence record openai:c3
    13. AI research evidence record anthropic:2-3
    14. AI research evidence record deepseek:c2
    15. AI research evidence record anthropic:4-1
    16. AI research evidence record openai:c2
    17. AI research evidence record openai:c1
    18. AI research evidence record openai:c4
    19. AI research evidence record anthropic:44-4
    20. AI research evidence record perplexity:8
    21. AI research evidence record anthropic:8-4
    22. AI research evidence record perplexity:2
    23. AI research evidence record kimi:asurgo-aflac-2026
    24. AI research evidence record anthropic:30-2
    25. AI research evidence record perplexity:3
    26. AI research evidence record openai:c1
    27. AI research evidence record anthropic:1-1
    28. AI research evidence record deepseek:c1
    29. AI research evidence record grok:web:0
    30. AI research evidence record perplexity:3
    31. AI research evidence record anthropic:4-1
    32. AI research evidence record anthropic:27-2
    33. AI research evidence record openai:c2
    34. AI research evidence record anthropic:30-2
    35. AI research evidence record anthropic:42-2
    36. AI research evidence record anthropic:44-2
    37. AI research evidence record anthropic:16-15
    38. AI research evidence record anthropic:10-2
    39. AI research evidence record anthropic:24-6
    40. AI research evidence record openai:c1
    41. AI research evidence record openai:c4
    42. AI research evidence record perplexity:8
    43. AI research evidence record grok:web:1
    44. AI research evidence record kimi:asurgo-aflac-2026
    45. AI research evidence record anthropic:16-2
    46. AI research evidence record perplexity:7
    47. AI research evidence record anthropic:30-9
    48. AI research evidence record anthropic:33-13
    49. AI research evidence record anthropic:33-15
    50. AI research evidence record anthropic:8-4
    51. AI research evidence record perplexity:2
    52. AI research evidence record kimi:asurgo-aflac-2026
    53. AI research evidence record anthropic:30-2
    54. AI research evidence record anthropic:42-2
    55. AI research evidence record anthropic:43-1
    56. AI research evidence record anthropic:27-2
    57. AI research evidence record openai:c2
    58. AI research evidence record anthropic:14-7
    59. AI research evidence record perplexity:10
    60. AI research evidence record anthropic:4-1
    61. AI research evidence record kimi:insurancegeek-rates-2026
    62. AI research evidence record deepseek:c2
    63. AI research evidence record anthropic:44-2
    64. AI research evidence record anthropic:16-15
    65. AI research evidence record anthropic:41-4
    66. AI research evidence record kimi:asurgo-aflac-2026
    67. AI research evidence record kimi:asurgo-aflac-2026
    68. AI research evidence record grok:web:1
    69. AI research evidence record anthropic:33-13
    70. AI research evidence record anthropic:33-15
    71. AI research evidence record anthropic:30-9
    72. AI research evidence record kimi:asurgo-aflac-2026
    73. AI research evidence record grok:web:1

Independent Sources

Other Sources

  • Best Burial Insurance for Seniors: 2026 Carrier Comparison: https://asurgo.com/best-burial-insurance-for-seniors/
  • Transamerica Premier: A Simplified Issue Life Company: https://finalexpensebrokerage.com/transamerica
  • Transamerica Final Expense Review - Guaranteed Life Insured: https://guaranteedlifeinsured.com/transamerica-review/
  • Transamerica Final Expense Review (2026): Rates & Our Score: https://www.consumeradviser.org/final-expense/reviews/transamerica-review
  • Additional AI research evidence73 records
    1. AI research evidence record anthropic:44-2
    2. AI research evidence record kimi:asurgo-aflac-2026
    3. AI research evidence record grok:web:1
    4. AI research evidence record openai:c4
    5. AI research evidence record openai:c1
    6. AI research evidence record anthropic:1-1
    7. AI research evidence record deepseek:c1
    8. AI research evidence record grok:web:0
    9. AI research evidence record grok:web:1
    10. AI research evidence record anthropic:34-8
    11. AI research evidence record deepseek:c4
    12. AI research evidence record openai:c3
    13. AI research evidence record anthropic:2-3
    14. AI research evidence record deepseek:c2
    15. AI research evidence record anthropic:4-1
    16. AI research evidence record openai:c2
    17. AI research evidence record openai:c1
    18. AI research evidence record openai:c4
    19. AI research evidence record anthropic:44-4
    20. AI research evidence record perplexity:8
    21. AI research evidence record anthropic:8-4
    22. AI research evidence record perplexity:2
    23. AI research evidence record kimi:asurgo-aflac-2026
    24. AI research evidence record anthropic:30-2
    25. AI research evidence record perplexity:3
    26. AI research evidence record openai:c1
    27. AI research evidence record anthropic:1-1
    28. AI research evidence record deepseek:c1
    29. AI research evidence record grok:web:0
    30. AI research evidence record perplexity:3
    31. AI research evidence record anthropic:4-1
    32. AI research evidence record anthropic:27-2
    33. AI research evidence record openai:c2
    34. AI research evidence record anthropic:30-2
    35. AI research evidence record anthropic:42-2
    36. AI research evidence record anthropic:44-2
    37. AI research evidence record anthropic:16-15
    38. AI research evidence record anthropic:10-2
    39. AI research evidence record anthropic:24-6
    40. AI research evidence record openai:c1
    41. AI research evidence record openai:c4
    42. AI research evidence record perplexity:8
    43. AI research evidence record grok:web:1
    44. AI research evidence record kimi:asurgo-aflac-2026
    45. AI research evidence record anthropic:16-2
    46. AI research evidence record perplexity:7
    47. AI research evidence record anthropic:30-9
    48. AI research evidence record anthropic:33-13
    49. AI research evidence record anthropic:33-15
    50. AI research evidence record anthropic:8-4
    51. AI research evidence record perplexity:2
    52. AI research evidence record kimi:asurgo-aflac-2026
    53. AI research evidence record anthropic:30-2
    54. AI research evidence record anthropic:42-2
    55. AI research evidence record anthropic:43-1
    56. AI research evidence record anthropic:27-2
    57. AI research evidence record openai:c2
    58. AI research evidence record anthropic:14-7
    59. AI research evidence record perplexity:10
    60. AI research evidence record anthropic:4-1
    61. AI research evidence record kimi:insurancegeek-rates-2026
    62. AI research evidence record deepseek:c2
    63. AI research evidence record anthropic:44-2
    64. AI research evidence record anthropic:16-15
    65. AI research evidence record anthropic:41-4
    66. AI research evidence record kimi:asurgo-aflac-2026
    67. AI research evidence record kimi:asurgo-aflac-2026
    68. AI research evidence record grok:web:1
    69. AI research evidence record anthropic:33-13
    70. AI research evidence record anthropic:33-15
    71. AI research evidence record anthropic:30-9
    72. AI research evidence record kimi:asurgo-aflac-2026
    73. AI research evidence record grok:web:1

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
37
Ranking mentions
5 of 7
Platform share
71%
Final consensus rank
#2

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

22 independent · 8 company-owned · 7 unclear

Evidence support

24 direct · 13 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

65ccaaaa2907619096ee05b9792139ac95f0da1c2e0051d79398b10f66cf8f47